Diagnostic criteria for cannabis withdrawal syndrome
- PMID: 22153944
- PMCID: PMC3311695
- DOI: 10.1016/j.drugalcdep.2011.11.007
Diagnostic criteria for cannabis withdrawal syndrome
Abstract
Objective: Cannabis withdrawal occurs in frequent users who quit, but there are no accepted diagnostic criteria for a cannabis withdrawal syndrome (CWS). This study evaluated diagnostic criteria for CWS proposed in DSM-V and two earlier proposals.
Method: A convenience sample of 384 adult, non-treatment-seeking lifetime cannabis smokers provided retrospective self-report data on their "most difficult" quit attempt without formal treatment, which was used in this secondary analysis. Prevalence, time of onset, and peak intensity (5-point Likert scale) for 39 withdrawal symptoms (drawn from the literature) were assessed via computer-administered questionnaire. Subject groups were compared using chi-square or ANOVA. Symptom clustering was evaluated with principal components analysis.
Results: 40.9% of subjects met the DSM-V criterion of ≥3 symptoms from a list of 7. There were no associations with sex, race, or type of cannabis preparation used. There were significant positive associations between duration or frequency of cannabis use prior to the quit attempt and experiencing CWS. Subjects with CWS had a significantly shorter duration of abstinence. Alternative syndromal criteria (dropping physical symptoms from DSM-V list; requiring ≥2 or ≥4 symptoms from a list of 11) yielded a similar prevalence of CWS and similar associations with prior cannabis use and relapse. The PCA yielded 12 factors, including some symptom clusters not included in DSM-V.
Conclusions: Findings support the concurrent and predictive validity of the proposed DSM-V CWS, but suggest that the list of withdrawal symptoms and number required for diagnosis warrant further evaluation.
Published by Elsevier Ireland Ltd.
Conflict of interest statement
No conflict declared.
Similar articles
-
DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults.Drug Alcohol Depend. 2019 Feb 1;195:170-177. doi: 10.1016/j.drugalcdep.2018.09.005. Epub 2018 Oct 22. Drug Alcohol Depend. 2019. PMID: 30361043 Free PMC article.
-
Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers.Drug Alcohol Depend. 2010 Sep 1;111(1-2):120-7. doi: 10.1016/j.drugalcdep.2010.04.010. Epub 2010 May 26. Drug Alcohol Depend. 2010. PMID: 20510550 Free PMC article.
-
Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients.Drug Alcohol Depend. 2010 Jan 15;106(2-3):133-41. doi: 10.1016/j.drugalcdep.2009.08.008. Epub 2009 Sep 23. Drug Alcohol Depend. 2010. PMID: 19783382
-
Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis.JAMA Netw Open. 2020 Apr 1;3(4):e202370. doi: 10.1001/jamanetworkopen.2020.2370. JAMA Netw Open. 2020. PMID: 32271390 Free PMC article.
-
Cannabis Withdrawal - A New Diagnostic Category in DSM-5.Isr J Psychiatry Relat Sci. 2014;51(4):270-5. Isr J Psychiatry Relat Sci. 2014. PMID: 25841223 Review.
Cited by
-
Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease.Med Cannabis Cannabinoids. 2021 Jun 21;4(2):97-106. doi: 10.1159/000517425. eCollection 2021 Winter. Med Cannabis Cannabinoids. 2021. PMID: 35224429 Free PMC article. Review.
-
Cannabis use outcomes by past-month binge drinking status in the general United States population.Drug Alcohol Depend. 2021 Nov 1;228:108997. doi: 10.1016/j.drugalcdep.2021.108997. Epub 2021 Aug 30. Drug Alcohol Depend. 2021. PMID: 34508962 Free PMC article.
-
Post-legalization changes in marijuana use in a sample of young California adults.Addict Behav. 2021 Apr;115:106782. doi: 10.1016/j.addbeh.2020.106782. Epub 2020 Dec 16. Addict Behav. 2021. PMID: 33388479 Free PMC article.
-
Marijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utility.SAGE Open Med. 2021 Mar 9;9:20503121211000909. doi: 10.1177/20503121211000909. eCollection 2021. SAGE Open Med. 2021. PMID: 33786179 Free PMC article. Review.
-
Considerations for Cannabinoids in Perioperative Care by Anesthesiologists.J Clin Med. 2022 Jan 22;11(3):558. doi: 10.3390/jcm11030558. J Clin Med. 2022. PMID: 35160010 Free PMC article. Review.
References
-
- Agrawal A, Pergadia ML, Lynskey MT. Is there evidence for symptoms of cannabis withdrawal in the National Epidemiologic Survey of Alcohol and Related Conditions? Am J Addict. 2008;17:199–208. - PubMed
-
- Allsop DJ, Norberg MM, Copeland J, Fu S, Budney AJ. The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend. 2011;119:123–129. - PubMed
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4. text revision. American Psychiatric Association; Washington, D.C.: 2000.
-
- Arendt M, Rosenberg R, Foldager L, Sher L, Munk-Jorgensen P. Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence. Am J Addict. 2007;16:461–467. - PubMed
-
- Budney AJ, Hughes JR. The cannabis withdrawal syndrome. Curr Opin Psychiatry. 2006;19:233–238. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous